Physician profile
Sara E Jepsen
NPI 1891324257
$398.92
in general payments reported to CMS, 2019-2025
9 companies · $83.05 in 2025
The $83.05 reported for 2025 was less than what a typical Critical Care Medicine (Nurse Practitioner) provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $142 · 2022: $47.53 · 2024: $126 · 2025: $83.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $124.50 | 2021 | |
| Stryker Corporation | $59.72 | 2025 | Clottriever Bold Catheter |
| Avita Medical Americas, LLC | $52.58 | 2024 | |
| Chiesi USA, INC. | $47.53 | 2022 | |
| Depuy Synthes Sales INC. | $26.92 | 2024 | Matrixrib |
| Solventum Corporation | $26.33 | 2024 | Prevena, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Astrazeneca Pharmaceuticals LP | $23.33 | 2025 | |
| Kerecis Limited | $20.62 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Heraeus Medical, LLC. | $17.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Jepsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.